AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
BrightSpring Health Services, Inc. Common Stock
Video analysis: BTSG
All videosNo video analysis for this stock yet. Request one from our team.
News: BTSG
BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell?
BrightSpring Health Services has surged 54% YTD on specialty pharmacy, infusion and EBITDA growth, but premium valuation and policy headwinds remain.
BTSG's Specialty Pharmacy Sales Up 30%: Will the Growth Continue?
BrightSpring Health Services' Specialty and Infusion sales rose 30%, backed by LDD growth, new launches and expansion into rare therapies.
BrightSpring Health Services: 44% Ebitda Growth Is Hard To Ignore
BrightSpring Health Services is rated buy, driven by rapid profitability growth, expanding Provider Services, and reduced financial leverage. In Q2, revenue grew 23% and adjusted EBITDA surged 44%, with management raising 2026 guidance for both revenue and EBITDA. BTSG's premium 34.38x FY1 P/E is justified by strong EBITDA growth and a forward PEG of 0.73x, with multiples declining to 22.19x by FY3.
Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?
BrightSpring Health Services is gaining acute infusion share with 20%+ volume growth, targeting 12-15 new states in a $20 billion market.
NVIDIA & 2 Profitable Stocks to Buy in September for Big Upside
NVDA's 63.7% net profit margin and 93.3% expected earnings growth put it among three profitable stocks positioned for market volatility.
BrightSpring Health Services, Inc. (NASDAQ:BTSG) Receives Consensus Rating of “Buy” from Brokerages
Shares of BrightSpring Health Services, Inc. (NASDAQ: BTSG - Get Free Report) have been assigned an average recommendation of "Buy" from the twenty research firms that are covering the company, Marketbeat.com reports. Eighteen equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The
William Blair Says These Stocks Are Must-Own Picks
William Blair reshuffled its September stock picks, bringing eight companies onto its Analyst Conviction List as the firm identified several new opportunities a
Canada Pension Plan Investment Board Purchases Shares of 51,300 BrightSpring Health Services, Inc. $BTSG
Canada Pension Plan Investment Board purchased a new position in BrightSpring Health Services, Inc. (NASDAQ: BTSG) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 51,300 shares of the company's stock, valued at approximately $3,578,000. Other large investors have
